FOURTH QUARTER 2021 FINANCIAL REPORT
04.02.2022
MANDATORY NOTIFICATION OF TRADE
22.12.2021
COMPLETED EXTRAORDINARY GENERAL MEETING
03.12.2021
HBC INGREDIENTS SUCCESSFULLY RECEIVE NEW DIETARY INGREDIENT (NDI) STATUS FROM THE US FDA
02.12.2021
18.11.2021
NOTICE OF EXTRAORDINARY GENERAL MEETING
08.11.2021
NEW POTENTIAL PHARMACEUTICAL DRUG LEADS BY HBC
05.11.2021
THIRD QUARTER 2021 FINANCIAL REPORT
THE BOARD OF DIRECTORS PROPOSES TO ELECT AMY NOVOGRATZ AS NEW DIRECTOR
04.11.2021
AQUA SPARK AS NEW STRATEGIC INVESTOR IN HBC